Sanofi (TSX:SNY)
Canada flag Canada · Delayed Price · Currency is CAD
22.36
0.00 (0.00%)
Nov 12, 2026, 3:57 PM EST

Sanofi Revenue

Sanofi had revenue of 15.23B EUR in the quarter ending September 30, 2026, with 15.66% growth. This brings the company's total for the last twelve months to 50.98B, up 11.00% year-over-year. In the year 2025, Sanofi had annual revenue of 46.72B with 5.49% growth.

Revenue (ttm)
50.98B EUR
Revenue Growth
+11.00%
P/S Ratio
2.01
Revenue / Employee
681.16K EUR
Employees
74,846
Market Cap
165.05B CAD

Revenue Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart
  • Pharma 35.69B 60.1%
  • Dupixent 15.71B 26.5%
  • Total Vaccine 7.94B 13.4%

By Geography

Chart
  • United States 22.18B 47.5%
  • Rest of World 12.28B 26.3%
  • Europe 9.17B 19.6%
  • Other 3.09B 6.6%
Fiscal year ended Dec 31, 2025 See the full Sanofi breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202546.72B2.43B5.49%
Dec 31, 202444.29B2.67B6.41%
Dec 31, 202341.62B1.06B2.61%
Dec 31, 202240.56B1.39B3.54%
Dec 31, 202139.18B1.81B4.83%
Dec 31, 202037.37B-262.00M-0.70%
Dec 31, 201937.63B1.95B5.48%
Dec 31, 201835.68B-544.00M-1.50%
Dec 31, 201736.22B1.53B4.40%
Dec 31, 201634.70B-165.00M-0.47%
Dec 31, 201534.86B2.86B8.94%
Dec 31, 201432.00B708.00M2.26%
Dec 31, 201331.29B-4.67B-12.98%
Dec 31, 201235.96B899.00M2.56%
Dec 31, 201135.06B1.02B3.00%
Dec 31, 201034.04B2.80B8.98%
Dec 31, 200931.23B2.42B8.38%
Dec 31, 200828.82B-390.00M-1.34%
Dec 31, 200729.21B-282.00M-0.96%
Dec 31, 200629.49B976.00M3.42%
Dec 31, 200528.51B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.